N4 Pharma PLC (LSE:N4P) - Share price


Stock Report

N4 Pharma PLC N4P

Last Price
GBX3.30

Day Change
0.00|0.00%

As of 17/10/2019
10:34:01 BST | GBX
Minimum 15 Minutes Delay.

Last Close3.30p
Day Range3.49 - 3.49
Mkt Cap3.20Mil
52-Wk Range2.70 - 15.21
Yield %-
ISINGB00BYW8QM32
Volume40,000
P/E-133.33
P/S-
P/CF-0.02

Share Price

Total Returns 16/10/2019

 Chg (%)  
More ...
N4 Pharma PLC4.76 
FTSE 100 TR GBP-1.62
 
Financials
201620172018
More ...
Income Statement
Turnover1.16--
Operating Profit-0.03-0.62-1.42
Net Profit-0.02-1.84-1.19
Reported EPS-0.08-2.84-1.32
Balance Sheet
Current Assets0.601.461.07
Non Current Assets0.520.000.00
Total Assets1.121.461.07
Current Liabilities0.080.180.19
Total Liabilities---
Total Equity1.041.280.88
Cash Flow
Operating Cash Flow-0.38-0.95-1.42
Net Change in Cash-0.421.31-0.53
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
28/05/2019Transfer outLuke Sebastian Cairns0.001970.00
10/04/2019PurchaseNigel Theobald4.4467,3432,990.00
10/04/2019PurchaseNigel Theobald4.4467,3432,990.00

Company Profile

N4 Pharma PLC is a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance. Its vaccines include Nuvac and Nuvec.

Sector

Drug Manufacturers - Major

Index

FTSE AIM All-Share

Next Event 14/05/2020

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-157.90
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Date12/11/9623/05/97
Ex-Div04/11/9619/05/97
Paid02/12/9601/07/97
Amnt17.2018.00
Directors
More ...
Non-Executive DirectorLuke Sebastian Cairns
Executive Director, Chief Executive OfficerNigel Theobald
Executive DirectorDavid Templeton
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.